The University of Chicago Header Logo

Connection

Robert Naclerio to Allergens

This is a "connection" page, showing publications Robert Naclerio has written about Allergens.
Connection Strength

3.879
  1. A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy. 2016 Jul; 30(4):269-73.
    View in: PubMed
    Score: 0.525
  2. Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration. J Appl Physiol (1985). 2013 Nov 01; 115(9):1262-7.
    View in: PubMed
    Score: 0.431
  3. Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis? Allergy Asthma Proc. 2009 Mar-Apr; 30(2):212-3; author reply 213-4.
    View in: PubMed
    Score: 0.316
  4. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
    View in: PubMed
    Score: 0.147
  5. Rhinitis and inhalant allergens. JAMA. 1997 Dec 10; 278(22):1842-8.
    View in: PubMed
    Score: 0.145
  6. Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
    View in: PubMed
    Score: 0.143
  7. A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
    View in: PubMed
    Score: 0.142
  8. Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med. 1997 Feb; 155(2):426-31.
    View in: PubMed
    Score: 0.137
  9. Treatment with hot, humid air reduces the nasal response to allergen challenge. J Allergy Clin Immunol. 1997 Jan; 99(1 Pt 1):77-86.
    View in: PubMed
    Score: 0.136
  10. Observations on the response of the nasal mucosa to allergens. Otolaryngol Head Neck Surg. 1994 Sep; 111(3 Pt 2):355-63.
    View in: PubMed
    Score: 0.116
  11. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
    View in: PubMed
    Score: 0.114
  12. The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
    View in: PubMed
    Score: 0.112
  13. Pollen lipidomics: lipid profiling exposes a notable diversity in 22 allergenic pollen and potential biomarkers of the allergic immune response. PLoS One. 2013; 8(2):e57566.
    View in: PubMed
    Score: 0.104
  14. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy. 2013 Jan; 27(1):48-53.
    View in: PubMed
    Score: 0.103
  15. The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992 Jul; 90(1):85-91.
    View in: PubMed
    Score: 0.099
  16. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinol Suppl. 1992; 14:52-6.
    View in: PubMed
    Score: 0.096
  17. Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
    View in: PubMed
    Score: 0.091
  18. Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
    View in: PubMed
    Score: 0.090
  19. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
    View in: PubMed
    Score: 0.080
  20. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
    View in: PubMed
    Score: 0.074
  21. Effect of genetic background on the response to bacterial sinusitis in mice. Arch Otolaryngol Head Neck Surg. 2006 Oct; 132(10):1102-8.
    View in: PubMed
    Score: 0.067
  22. The role of inflammatory mediators in allergic rhinitis. Ear Nose Throat J. 1986 May; 65(5):206-12.
    View in: PubMed
    Score: 0.065
  23. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct; 128(4):597-602.
    View in: PubMed
    Score: 0.054
  24. Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol. 2000 Dec; 106(6):1045-52.
    View in: PubMed
    Score: 0.045
  25. Hot, humid air partially inhibits the nasal response to allergen provocation. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):749-54.
    View in: PubMed
    Score: 0.043
  26. Pathophysiology of perennial allergic rhinitis. Allergy. 1997; 52(36 Suppl):7-13.
    View in: PubMed
    Score: 0.034
  27. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015 Nov; 70(11):1372-92.
    View in: PubMed
    Score: 0.031
  28. Local nasal immunotherapy. Has the time come? Am J Respir Crit Care Med. 1995 Aug; 152(2):425-6.
    View in: PubMed
    Score: 0.031
  29. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 1):1006-16.
    View in: PubMed
    Score: 0.029
  30. The effect of intranasal carbon dioxide on the acute response to nasal challenge with allergen. Allergy Asthma Proc. 2011 May-Jun; 32(3):206-12.
    View in: PubMed
    Score: 0.023
  31. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991 Apr; 87(4):855-66.
    View in: PubMed
    Score: 0.023
  32. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Nov-Dec; 31(6):483-92.
    View in: PubMed
    Score: 0.022
  33. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
    View in: PubMed
    Score: 0.022
  34. Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Clin Exp Allergy. 1990 Sep; 20(5):571-9.
    View in: PubMed
    Score: 0.022
  35. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
    View in: PubMed
    Score: 0.022
  36. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010 Jul-Aug; 24(4):286-90.
    View in: PubMed
    Score: 0.022
  37. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
    View in: PubMed
    Score: 0.020
  38. Epithelial shedding is associated with nasal reactions to cold, dry air. J Allergy Clin Immunol. 2006 Jun; 117(6):1351-8.
    View in: PubMed
    Score: 0.016
  39. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
    View in: PubMed
    Score: 0.016
  40. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
    View in: PubMed
    Score: 0.015
  41. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov; 72(5):1678-85.
    View in: PubMed
    Score: 0.014
  42. Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
    View in: PubMed
    Score: 0.013
  43. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998 Jan; 28(1):92-100.
    View in: PubMed
    Score: 0.009
  44. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992 Jun; 89(6):1098-110.
    View in: PubMed
    Score: 0.006
  45. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol. 1986 Aug 15; 137(4):1323-8.
    View in: PubMed
    Score: 0.004
  46. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul; 76(1):191-7.
    View in: PubMed
    Score: 0.004
  47. Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
    View in: PubMed
    Score: 0.004
  48. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21; 310(25):1626-30.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.